SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 217 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $685,941 | -48.9% | 774,200 | -9.4% | 0.00% | -33.3% |
| Q3 2022 | $1,341,861 | -21.9% | 854,600 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,717,873 | +1135.9% | 854,600 | +2767.8% | 0.00% | – |
| Q4 2021 | $139,000 | -38.8% | 29,800 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $227,000 | -9.9% | 29,800 | -78.3% | 0.00% | 0.0% |
| Q1 2020 | $252,000 | -45.7% | 137,200 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $464,000 | +52.6% | 137,200 | -3.4% | 0.00% | 0.0% |
| Q3 2019 | $304,000 | -20.0% | 142,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $380,000 | -38.1% | 142,000 | +9.8% | 0.00% | -50.0% |
| Q1 2019 | $614,000 | -11.8% | 129,300 | -55.4% | 0.00% | -33.3% |
| Q4 2018 | $696,000 | -45.5% | 290,100 | 0.0% | 0.00% | -40.0% |
| Q3 2018 | $1,276,000 | +151.2% | 290,100 | +310.9% | 0.01% | +150.0% |
| Q2 2018 | $508,000 | – | 70,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Oaktree Fund Advisors, LLC | 66,000 | $503,000 | 48.93% |
| SABBY MANAGEMENT, LLC | 1,698,107 | $12,957,000 | 1.75% |
| EMFO, LLC | 233,008 | $1,778,000 | 1.57% |
| swisspartners Ltd. | 110,000 | $839,000 | 0.65% |
| HERITAGE WEALTH MANAGEMENT, LLC | 150,000 | $1,145,000 | 0.41% |
| Donald L. Hagan, LLC | 42,929 | $328,000 | 0.19% |
| COLLECTIVE FAMILY OFFICE LLC | 44,203 | $337,000 | 0.14% |
| Spectrum Wealth Advisory Group, LLC | 18,093 | $138,000 | 0.14% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 100,000 | $763,000 | 0.13% |
| Cormorant Asset Management, LP | 400,000 | $3,052,000 | 0.12% |